APA (7th ed.) Citation

RS, W., JJ, K., LC, C., C, M., 3rd, B. C., FM, W., . . . AA, S. (2024). Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis. Seminars in arthritis and rheumatism, 67, 152460. https://doi.org/10.1016/j.semarthrit.2024.152460

Chicago Style (17th ed.) Citation

RS, Wallwork, Kotzin JJ, Cappelli LC, Mecoli C, Bingham CO 3rd, Wigley FM, Wilson PC, DiRenzo DD, and Shah AA. "Immune Checkpoint Inhibitor Therapy in Patients with Cancer and Pre-existing Systemic Sclerosis." Seminars in Arthritis and Rheumatism 67 (2024): 152460. https://doi.org/10.1016/j.semarthrit.2024.152460.

MLA (9th ed.) Citation

RS, Wallwork, et al. "Immune Checkpoint Inhibitor Therapy in Patients with Cancer and Pre-existing Systemic Sclerosis." Seminars in Arthritis and Rheumatism, vol. 67, 2024, p. 152460, https://doi.org/10.1016/j.semarthrit.2024.152460.